World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
15415
World Ranking
3005
National Ranking
1409

Robert Parks publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert Parks sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 142 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert Parks D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Parks sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert Parks is affiliated with Duke University in the United States. Their research spans multiple fields with a strong focus on medicine and immunology and microbiology. Within these broader disciplines, their work is concentrated in subfields including infectious diseases, immunology, virology, molecular biology, and animal science and zoology.

Their main research topics cover a range of areas related to viral infections and immune responses. These include SARS-CoV-2 and COVID-19 research, HIV research and treatment, animal virus infections studies, immune cell function and interaction, monoclonal and polyclonal antibodies research, vaccines and immunoinformatics approaches, and viral gastroenteritis research and epidemiology.

Among the recent papers authored or co-authored by Robert Parks are:

  • Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity, 2021, Science
  • A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice, 2020, Immunity
  • D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction, 2020, Cell Reports
  • In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies, 2021, Cell
  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses, 2021, Nature

Robert Parks has collaborated frequently with several researchers, including Barton F. Haynes, Kevin O. Saunders, Maggie Barr, Robert J. Edwards, and David C. Montefiori. These coauthor relationships highlight ongoing collaborative efforts in their fields of study.

Their research has been published predominantly in well-recognized publication venues. Frequent outlets include bioRxiv (Cold Spring Harbor Laboratory), Cell Reports, UNC Libraries, Science Translational Medicine, and Nature Communications.

Best Publications

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • Controlling the SARS-CoV-2 spike glycoprotein conformation.

    Rory Henderson;Rory Henderson;Robert J. Edwards;Robert J. Edwards;Katayoun Mansouri;Katarzyna Janowska

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.

    Sophie M.-C. Gobeil;Katarzyna Janowska;Shana McDowell;Katayoun Mansouri

  • Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

    Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates

  • A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.

    Dorottya Laczkó;Michael J. Hogan;Sushila A. Toulmin;Philip Hicks

  • Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

    Marie Pancera;Syed Shahzad-Ul-Hussan;Nicole A. Doria-Rose;Jason S. McLellan

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

  • Structural diversity of the SARS-CoV-2 Omicron spike

    Unknown

  • D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.

    Sophie M.-C. Gobeil;Katarzyna Janowska;Shana McDowell;Katayoun Mansouri

  • High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.

    Hua-Xin Liao;Marc C. Levesque;Ashleigh Nagel;Ashlyn Dixon

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

    Dapeng Li;Robert J. Edwards;Kartik Manne;David R. Martinez

  • Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

    Sampa Santra;Hua-Xin Liao;Ruijin Zhang;Mark Muldoon

  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.

    Kevin O. Saunders;Esther Lee;Robert Parks;David R. Martinez

  • Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-infected Donor: Implications for Vaccine Design

    Mattia Bonsignori;David C. Montefiori;Xueling Wu;Xi Chen

  • Controlling the SARS-CoV-2 Spike Glycoprotein Conformation

    Rory Henderson;Robert J Edwards;Katayoun Mansouri;Katarzyna Janowska

Frequent Co-Authors

Barton F. Haynes
Barton F. Haynes Duke University
David C. Montefiori
David C. Montefiori Duke University
Hua-Xin Liao
Hua-Xin Liao Duke University
S. Munir Alam
S. Munir Alam Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
M. Anthony Moody
M. Anthony Moody Duke University
Kevin O. Saunders
Kevin O. Saunders Duke University
Mattia Bonsignori
Mattia Bonsignori Duke University
Richard M. Scearce
Richard M. Scearce Duke University
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students consider entering the nursing field through accessible programs that complement immunological expertise. For example, accelerated np programs offer a fast track for registered nurses aiming to become nurse practitioners, allowing for advanced clinical roles in immunology-related settings.

Non-nurses seeking a nursing career can benefit from online adn programs for non nurses, which provide flexible learning paths without compromising on essential skills. These programs are designed to accommodate different backgrounds, making a nursing transition feasible for many.

When choosing a program, some may prefer accelerated nursing programs that are easier to get into but still maintain quality education and clinical preparation. These paths are ideal for those eager to enter the workforce quickly while focusing on specialized fields like immunology.

Additionally, fastest and easiest lpn programs offer a practical route for healthcare entry-level roles. Licensed Practical Nurses often work closely with immunologists in patient care, making this a viable starting point for building healthcare experience.

Each of these options provides valuable pathways to combine nursing skills with immunology, enhancing both academic knowledge and career flexibility.

Explore these programs further through the following resources: accelerated np programs, online adn programs for non nurses, accelerated nursing programs, and fastest and easiest lpn programs.

Best Scientists Citing Robert Parks

Trending Scientists

Recently Published Articles